title: Engineering catalytically defective forms of HIV protease to modulate its activity.
authors.affiliation: Department of Pharmaceutical Chemistry, University of California at San Francisco 94143, USA.
authors.forename: C S
authors.initials: CS
authors.lastname: Craik
authors.forename: L M
authors.initials: LM
authors.lastname: Babé
authors.forename: D
authors.initials: D
authors.lastname: Dauber
authors.forename: F
authors.initials: F
authors.lastname: McPhee
authors.forename: J
authors.initials: J
authors.lastname: Rosé
authors.forename: A
authors.initials: A
authors.lastname: Unal
mesh_terms: D000818:Animals; D019380:Anti-HIV Agents; D002384:Catalysis; D019281:Dimerization; D016333:HIV Protease / Q000235:genetics* / Q000378:metabolism*; D015497:HIV-1 / Q000201:enzymology* / Q000502:physiology; D006801:Humans; D015202:Protein Engineering; D014771:Virion
chemical_list: D019380:Anti-HIV Agents; D016333:HIV Protease